Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo

Cited 4 time in webofscience Cited 0 time in scopus
  • Hit : 288
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorPark, Hyun-Jiko
dc.contributor.authorJeon, Eun Jeko
dc.contributor.authorLee, Jung Seungko
dc.contributor.authorHong, Sang Hyeonko
dc.contributor.authorCho, Ann-Nako
dc.contributor.authorLee, Joanko
dc.contributor.authorMoon, Jae-Suko
dc.contributor.authorJung, Kyeong-Eunko
dc.contributor.authorOh, Jong-Wonko
dc.contributor.authorLee, Haeshinko
dc.contributor.authorCho, Seung-Wooko
dc.date.accessioned2017-01-18T02:43:20Z-
dc.date.available2017-01-18T02:43:20Z-
dc.date.created2017-01-02-
dc.date.created2017-01-02-
dc.date.issued2016-11-
dc.identifier.citationADVANCED HEALTHCARE MATERIALS, v.5, no.22, pp.2931 - 2941-
dc.identifier.issn2192-2640-
dc.identifier.urihttp://hdl.handle.net/10203/219641-
dc.description.abstractSmall interfering RNA (siRNA) delivery can provide an effective therapy for treating viral diseases by silencing genes involved in viral replication. In this study, a liver-targeting formulation of lipidoid nanoparticle for delivery of siRNA that targets protein kinase C-related kinase 2 (PRK2) to inhibit hepatitis C virus (HCV) replication is reported. The most effective, minimally cytotoxic lipidoid for siRNA delivery to hepatic cells is identified from a small library of alkyl epoxide-polyamine conjugates. In vitro transfection of PRK2 siRNA (siPRK2) using this lipidoid induces significant silencing of PRK2 (approximate to 80%), suppressing HCV replication in human hepatic cells transfected with the HCV subgenomic replicon. Systemic administration of siPRK2 using the lipidoid nanoparticles results in significant reduction of host PRK2 in the mouse liver (approximate to 60%). This treatment significantly suppresses HCV replication in an HCV-xenograft mouse model. siRNA delivery to the liver is further improved via galactosylation of the lipidoid. Compared with the unmodified lipidoid formulation, galactosylated lipidoids induce greater silencing of host PRK2 in mouse livers (approximate to 80%) and more rapid suppression of HCV replication in an HCV-xenograft mouse. This study suggests that galactosylated lipidoid nanoparticles could provide a treatment for hepatitis C by mediating delivery of anti-viral RNA interference therapeutics to the liver.-
dc.languageEnglish-
dc.publisherWILEY-BLACKWELL-
dc.subjectENHANCED CELLULAR UPTAKE-
dc.subjectSIRNA DELIVERY-
dc.subjectPROTEIN-KINASE-
dc.subjectGENE DELIVERY-
dc.subjectALTERED PHARMACOKINETICS-
dc.subjectCOMBINATORIAL LIBRARY-
dc.subjectTARGETED DELIVERY-
dc.subjectVIRUS-REPLICATION-
dc.subjectSYSTEMIC DELIVERY-
dc.subjectCANCER-CELLS-
dc.titleGalactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo-
dc.typeArticle-
dc.identifier.wosid000388999900009-
dc.identifier.scopusid2-s2.0-84995896931-
dc.type.rimsART-
dc.citation.volume5-
dc.citation.issue22-
dc.citation.beginningpage2931-
dc.citation.endingpage2941-
dc.citation.publicationnameADVANCED HEALTHCARE MATERIALS-
dc.identifier.doi10.1002/adhm.201600416-
dc.contributor.localauthorLee, Haeshin-
dc.contributor.nonIdAuthorPark, Hyun-Ji-
dc.contributor.nonIdAuthorJeon, Eun Je-
dc.contributor.nonIdAuthorLee, Jung Seung-
dc.contributor.nonIdAuthorCho, Ann-Na-
dc.contributor.nonIdAuthorLee, Joan-
dc.contributor.nonIdAuthorMoon, Jae-Su-
dc.contributor.nonIdAuthorJung, Kyeong-Eun-
dc.contributor.nonIdAuthorOh, Jong-Won-
dc.contributor.nonIdAuthorCho, Seung-Woo-
dc.description.isOpenAccessN-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorgalactosylation-
dc.subject.keywordAuthorhepatitis C virus-
dc.subject.keywordAuthorlipidoid nanoparticles-
dc.subject.keywordAuthorprotein kinase C-related kinase 2-
dc.subject.keywordAuthorsmall interfering RNA-
dc.subject.keywordPlusENHANCED CELLULAR UPTAKE-
dc.subject.keywordPlusSIRNA DELIVERY-
dc.subject.keywordPlusPROTEIN-KINASE-
dc.subject.keywordPlusGENE DELIVERY-
dc.subject.keywordPlusALTERED PHARMACOKINETICS-
dc.subject.keywordPlusCOMBINATORIAL LIBRARY-
dc.subject.keywordPlusTARGETED DELIVERY-
dc.subject.keywordPlusVIRUS-REPLICATION-
dc.subject.keywordPlusSYSTEMIC DELIVERY-
dc.subject.keywordPlusCANCER-CELLS-
Appears in Collection
CH-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 4 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0